Shareholding disclosure

ADDEX THERAPEUTICS LTD

Declared position

57.15%

Threshold

Crossed downwards

Timeline

Published

03.11.2022

Transaction

26.10.2022

Voting rights breakdown

Voting rights acquired18.65%

Voting rights sold57.15%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAMB1000C3

Beneficial owner

ADDEX THERAPEUTICS LTD

Declared address

ADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

Crossing down of 66 2/3% threshold on sale position following the exercise of 17,240,133 ESOP and 198,750 ESC.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

ADDEX THERAPEUTICS LTD

Addex Therapeutics Ltd03.11.2022TAMB1000C3

Disclosure summary

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd on the disposal side, published by SIX Exchange Regulation on 03.11.2022, at 57.15% of voting rights. Notice category: Single shareholder.

Disclosed position

57.15%

Voting rights sold

Voting rights acquired18.65%

Voting rights sold57.15%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd, published on 03.11.2022.

Publication date03.11.2022

Transaction date26.10.2022

Issuing companyAddex Therapeutics Ltd

Beneficial ownerADDEX THERAPEUTICS LTD

Declared addressADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

CategorySingle shareholder

Voting rights acquired18.65%

Voting rights sold57.15%

Below threshold0%

ExchangeXSWX

Notification IDTAMB1000C3

Commercial register

CHE-113.514.094

Registered

Zefix record

Conditions

Crossing down of 66 2/3% threshold on sale position following the exercise of 17,240,133 ESOP and 198,750 ESC.

Source: SIX Exchange Regulation · Publication date: 03.11.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open